Yunkang Group Ltd
HKEX:2325
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Y
|
Yunkang Group Ltd
HKEX:2325
|
CN |
|
F
|
Falck Renewables SpA
LSE:0NXV
|
IT |
|
CA Immobilien Anlagen AG
LSE:0MIP
|
AT |
|
VIP Clothing Ltd
NSE:VIPCLOTHNG
|
IN |
|
Shinpo Co Ltd
TSE:5903
|
JP |
|
S
|
Sunedison Infrastructure Ltd
BSE:531260
|
IN |
|
Zurn Water Solutions Corp
NYSE:ZWS
|
US |
|
Godrej Agrovet Ltd
NSE:GODREJAGRO
|
IN |
|
Fermenta Biotech Ltd
BSE:506414
|
IN |
Yunkang Group Ltd
Yunkang Group Ltd is a CN-based company operating in industry. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2022-05-18. Yunkang Group Ltd is a China-based Company mainly engaged in the provision of diagnosis testing services. The firm operates three segments. Diagnosis Testing segment provides diagnosis testing to hospital and non-medical clients, mainly including routine diagnostic testing, routine pathological examination, infectious disease diagnostic testing, genetic disease diagnostic testing and early cancer detection. Hospital Management Business segment provides management services for the community clinics. Research & Development Institution segment is engaged in the research and development of testing kits. The firm primarily provides services for hospitals and other medical institutions, and commercial entities such as financial institutions and insurance companies.
Yunkang Group Ltd is a CN-based company operating in industry. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2022-05-18. Yunkang Group Ltd is a China-based Company mainly engaged in the provision of diagnosis testing services. The firm operates three segments. Diagnosis Testing segment provides diagnosis testing to hospital and non-medical clients, mainly including routine diagnostic testing, routine pathological examination, infectious disease diagnostic testing, genetic disease diagnostic testing and early cancer detection. Hospital Management Business segment provides management services for the community clinics. Research & Development Institution segment is engaged in the research and development of testing kits. The firm primarily provides services for hospitals and other medical institutions, and commercial entities such as financial institutions and insurance companies.
